36 related articles for article (PubMed ID: 16312805)
1. Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy.
Takata R; Katagiri T; Kanehira M; Shuin T; Miki T; Namiki M; Kohri K; Tsunoda T; Fujioka T; Nakamura Y
Cancer Sci; 2007 Jan; 98(1):113-7. PubMed ID: 17116130
[TBL] [Abstract][Full Text] [Related]
2. [MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
Seguchi T; Nakano E; Miki T; Kondoh M; Nishimura K; Nakamura N; Okuyama A
Gan To Kagaku Ryoho; 1994 Jan; 21(1):59-65. PubMed ID: 8291917
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of metastatic cancer of the bladder. Apropos of 50 patients treated with M-VAC].
Beuzeboc P; Dhote R; Thiounn N; Flam T; Zerbib M; Debré B; Pouillart P
Cancer Radiother; 1998 Apr; 2 Suppl 1():92s-96s. PubMed ID: 9749087
[TBL] [Abstract][Full Text] [Related]
4. M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.
Scher H; Herr H; Sternberg C; Fair W; Bosl G; Morse M; Sogani P; Watson R; Darshaw D; Reuter V
Prog Clin Biol Res; 1990; 353():179-86. PubMed ID: 2217417
[No Abstract] [Full Text] [Related]
5. [Two cases of urothelial cancer responsive to high-dose-intensity methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy].
Fukuda H; Mitsumori K; Minagawa S; Kumazawa T; Tadachi K; Iinuma M; Satoh S; Satoh K; Habuchi T; Kato T
Hinyokika Kiyo; 2005 Feb; 51(2):113-6. PubMed ID: 15773365
[TBL] [Abstract][Full Text] [Related]
6. M-VAC regimen in murine bladder tumors.
Brausi M; Hickey DP; Blatnik AF; Soloway MS
J Chemother; 1989 Jul; 1(4 Suppl):1132-3. PubMed ID: 16312805
[No Abstract] [Full Text] [Related]
7. Neo-adjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) for infiltrating bladder cancer: initial results in Italy.
Sternberg CN
Prog Clin Biol Res; 1990; 353():143-52. PubMed ID: 2217412
[No Abstract] [Full Text] [Related]
8. [Place of chemotherapy in the treatment of invasive bladder tumors].
Pariente JL; Theodore C; Davin JL; Rischmann P; Chopin D
Prog Urol; 1999 Apr; 9(2):219-24. PubMed ID: 10370944
[TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
Miyanaga N; Akaza H
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human granulocyte colony-stimulating factor in patients receiving methotrexate/vinblastine/doxorubicin/cisplatin therapy for the treatment of transitional cell carcinoma of the urinary tract.
Akaza H; Kotake T; Miyanaga N; Koiso K
Semin Oncol; 1994 Feb; 21(1 Suppl 1):70-4. PubMed ID: 7512280
[No Abstract] [Full Text] [Related]
11. The evolving role of chemotherapy in advanced urothelial cancer.
Calabrò F; Sternberg CN
Curr Opin Support Palliat Care; 2007 Oct; 1(3):180-6. PubMed ID: 18685360
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
